The primary occurrence of mucoepidermoid carcinoma (MEC) of the conjunctiva is extremely rare, aggressive, and easily mistaken for squamous cell carcinoma. With fewer than 50 cases reported in the literature, there is no consensus on the most effective treatment. Radiation is an alternative to enucleation or orbital exenteration with the potential of eye preservation. We investigated several radiation approaches for a case with postresection positive margins at Tenon's fascia, and reported the patient's clinical course during the treatment and for a short time thereafter. An otherwise healthy 64-year-old male presented with MEC extending to the deep margin at the Tenon's fascia. Plans for 4 different radiation therapy treatment modalities (Intensity Modulated Radiation Therapy [IMRT], Volumetric Modulated Radiation Therapy [VMAT], double scattering (DS) proton, and reverse eye plaque low dose rate [LDR] ) were created and compared based on tumor coverage and normal tissue doses. The planning target volume (PTV) was too large and nonuniform for an eye plaque application. Using the largest plaque available (22 mm), the calculated minimum dose to the PTV was 57% while the dose to the skin was 1000% of the prescription. The proton plan completely spared the contralateral ocular structures and reduced the max doses to the ipsilateral macula and optic nerve, but was not clinically available at the time of treatment. The IMRT and VMAT plans produced similar dose distributions to each other, but VMAT further minimized dose to the ipsilateral eye. Due to the uniqueness of this case, a thorough study of the available radiation treatment options was deemed necessary. All of the external beam treatment techniques produced acceptable plans with VMAT producing the best available plan in this case. The patient was treated with the VMAT plan with a prescription of 6600 cGy in 30 fractions. At 5 months post-treatment, the patient is recovering from expected acute responses to radiation with follow ups scheduled.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Medical Dosimetry
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Primary cutaneous versus salivary gland origin mucoepidermoid carcinoma.Am J Dermatopathol. 2015; 37: e26-e30
- Primary cutaneous mucoepidermoid carcinoma.Am J Dermatopathol. 2010; 32: 618-620
- Bulbar conjunctival metastasis from mucoepidermoid carcinoma of parotid—A case report and review of literature.World J Surg Oncol. 2017; 15: 10
- Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma.Cancer. 2008; 113: 2082-2089
- Conjunctival mucoepidermoid carcinoma: Clear cell variant.Arch Ophthalmol. 2005; 123: 1265-1268
- Mucoepidermoid carcinoma of the conjunctiva: A series of three cases.Ophthalmology. 2000; 107: 801-805
- Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.Med Phys. 2012; 39: 6161-6184
- Effect of wetness level on the suitability of wet gauze as a substitute for Superflab as a bolus material for use with 6 mv photons.Vet Radiol Ultrasound. 2009; 50: 555-559
- Mucoepidermoid carcinoma of the conjunctiva. A clinicopathologic study of five cases..Cancer. 1976; 38: 1699-1709
- A case of conjunctival mucoepidermoid carcinoma in Australia.Clin Ophthalmol. 2014; 8: 11-14
Marks, L.B., Yorke, E.D.; Jackson, A.; et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 76: p. S10-S19.
- Radiobiology for the Radiologist.Wolters Kluwer Health, 2012
- Tolerance of normal tissue to therapeutic irradiation.Int J Radiat Oncol Biol Phys. 1991; 21: 109-122
Published online: October 23, 2018
Accepted: September 19, 2018
Received in revised form: September 18, 2018
Received: April 17, 2018
Published by Elsevier Inc. on behalf of American Association of Medical Dosimetrists.